Palliative Care in High-Grade Glioma: A Review

High-grade glioma (HGG) is characterized by debilitating neurologic symptoms and poor prognosis. Some of the suffering this disease engenders may be ameliorated through palliative care, which improves quality of life for seriously ill patients by optimizing symptom management and psychosocial suppor...

Full description

Bibliographic Details
Main Authors: Rita C. Crooms, Nathan E. Goldstein, Eli L. Diamond, Barbara G. Vickrey
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Brain Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3425/10/10/723
id doaj-83a4dbccea524e539b99a10fbdbe9b3e
record_format Article
spelling doaj-83a4dbccea524e539b99a10fbdbe9b3e2020-11-25T03:37:34ZengMDPI AGBrain Sciences2076-34252020-10-011072372310.3390/brainsci10100723Palliative Care in High-Grade Glioma: A ReviewRita C. Crooms0Nathan E. Goldstein1Eli L. Diamond2Barbara G. Vickrey3Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY 10029, USAIcahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY 10029, USADepartment of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USAIcahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY 10029, USAHigh-grade glioma (HGG) is characterized by debilitating neurologic symptoms and poor prognosis. Some of the suffering this disease engenders may be ameliorated through palliative care, which improves quality of life for seriously ill patients by optimizing symptom management and psychosocial support, which can be delivered concurrently with cancer-directed treatments. In this article, we review palliative care needs associated with HGG and identify opportunities for primary and specialty palliative care interventions. Patients with HGG and their caregivers experience high levels of distress due to physical, emotional, and cognitive symptoms that negatively impact quality of life and functional independence, all in the context of limited life expectancy. However, patients typically have limited contact with specialty palliative care until the end of life, and there is no established model for ensuring their palliative care needs are met throughout the disease course. We identify low rates of advance care planning, misconceptions about palliative care being synonymous with end-of-life care, and the unique neurologic needs of this patient population as some of the potential barriers to increased palliative interventions. Further research is needed to define the optimal roles of neuro-oncologists and palliative care specialists in the management of this illness and to establish appropriate timing and models for palliative care delivery.https://www.mdpi.com/2076-3425/10/10/723palliative caresupportive caregliomaquality of life
collection DOAJ
language English
format Article
sources DOAJ
author Rita C. Crooms
Nathan E. Goldstein
Eli L. Diamond
Barbara G. Vickrey
spellingShingle Rita C. Crooms
Nathan E. Goldstein
Eli L. Diamond
Barbara G. Vickrey
Palliative Care in High-Grade Glioma: A Review
Brain Sciences
palliative care
supportive care
glioma
quality of life
author_facet Rita C. Crooms
Nathan E. Goldstein
Eli L. Diamond
Barbara G. Vickrey
author_sort Rita C. Crooms
title Palliative Care in High-Grade Glioma: A Review
title_short Palliative Care in High-Grade Glioma: A Review
title_full Palliative Care in High-Grade Glioma: A Review
title_fullStr Palliative Care in High-Grade Glioma: A Review
title_full_unstemmed Palliative Care in High-Grade Glioma: A Review
title_sort palliative care in high-grade glioma: a review
publisher MDPI AG
series Brain Sciences
issn 2076-3425
publishDate 2020-10-01
description High-grade glioma (HGG) is characterized by debilitating neurologic symptoms and poor prognosis. Some of the suffering this disease engenders may be ameliorated through palliative care, which improves quality of life for seriously ill patients by optimizing symptom management and psychosocial support, which can be delivered concurrently with cancer-directed treatments. In this article, we review palliative care needs associated with HGG and identify opportunities for primary and specialty palliative care interventions. Patients with HGG and their caregivers experience high levels of distress due to physical, emotional, and cognitive symptoms that negatively impact quality of life and functional independence, all in the context of limited life expectancy. However, patients typically have limited contact with specialty palliative care until the end of life, and there is no established model for ensuring their palliative care needs are met throughout the disease course. We identify low rates of advance care planning, misconceptions about palliative care being synonymous with end-of-life care, and the unique neurologic needs of this patient population as some of the potential barriers to increased palliative interventions. Further research is needed to define the optimal roles of neuro-oncologists and palliative care specialists in the management of this illness and to establish appropriate timing and models for palliative care delivery.
topic palliative care
supportive care
glioma
quality of life
url https://www.mdpi.com/2076-3425/10/10/723
work_keys_str_mv AT ritaccrooms palliativecareinhighgradegliomaareview
AT nathanegoldstein palliativecareinhighgradegliomaareview
AT elildiamond palliativecareinhighgradegliomaareview
AT barbaragvickrey palliativecareinhighgradegliomaareview
_version_ 1724545240394629120